IL18 and ischemic stroke: Previous reports showed that JQ1-treated animals exhibit a marked reduction in the expression of pro-inflammatory mediators IL-1β, IL-6, IL-17, IL-18, and TNF-α in the brain in rodent ischemic stroke models [5, 47].